How to Use Bivalirudin
Complete guide to Bivalirudin dosing, administration, timing, and protocol recommendations.
Quick Overview
Bivalirudin is an FDA-approved anticoagulant (brand name Angiomax) and a synthetic 20 amino acid peptide based on hirudin, the natural anticlotting molecule from medicinal leeches. It is given intravenously during PCI and in some acute coronary syndrome and heparin-induced-thrombocytopenia situations to prevent clots while keeping bleeding lower than older drugs. This is a hospital-grade prescription anticoagulant with a long clinical track record, approved by the FDA in 2000.
Dosing Guidelines
Common Dose
Limited community data available
Frequency
See research protocols
Dose Range
See research dosing
Note: Limited anecdotal data. Refer to research dosing section.
Administration Method
IV bolus and infusion
Best Time to Take
Morning or as directed
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Protocol Duration
Duration of procedure
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Bleeding (28%)
- •Headache
- •Thrombocytopenia
- •Hypotension
- •Acute stent thrombosis (higher than heparin)
Frequently Asked Questions
What is the recommended dose for Bivalirudin?
Limited community data available
How do you administer Bivalirudin?
IV bolus and infusion
When is the best time to take Bivalirudin?
Morning or as directed
How long should you use Bivalirudin?
Duration of procedure
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.